Key Drivers
- Heavy leverage
- Negative equity
- Positive annual EBITDA
AIAI Summary
SNDA is no longer just a recovering operator but a capital‑intensive consolidator after the $1.8B CNL merger, so the investment hinges less on same‑store recovery and more on whether management can convert NOI gains into free cash flow while executing the $900M financing and $75M integration plan without dilutive raises. Monitor quarterly NOI-to-FCF conversion, covenant headroom/refinancing milestones, and pace/price of any asset dispositions—missed targets or tighter credit conditions materially increase downside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Heavy leverage
- •Negative equity
- •Positive annual EBITDA
SNDA shows asset-backed EBITDA potential but acute solvency and profitability stress—heavy debt, negative equity, weak liquidity, and widening quarterly losses despite positive annual EBITDA.
Price Behavior
Key Price Behavior Insights:
- •Below last month SMA
- •Defined support
- •Lower highs sequence
SNDA at $31.78 is about 10% below its last month SMA (~$35.44), showing short-term bearish momentum but with support around $31.3–$32.0 that could limit downside.
Fell from $37.34 on 2026-03-04 to current (~15% swing), indicating elevated short-term volatility
Sentiment & News
Key News Insights:
- •Portfolio expansion
- •Wider-than-expected loss
- •Active investor outreach
Sonida closed a $1.8B merger to acquire CNL Healthcare while reporting a wider-than-expected Q4 loss, reflecting big portfolio expansion amid near-term earnings pressure.
The merger materially increases scale and growth optionality but near-term earnings deterioration and integration risks could pressure the stock until synergies and cash-flow improvements materialize
Similar Companies in Healthcare
Other companies in the same sector with AI ratings